Citigroup’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
1,322,859
+576,765
| +77% | +$1.12M | ﹤0.01% | 1851 |
|
|
2025
Q1 | $1.31M | Sell |
746,094
-106,661
| -13% | -$188K | ﹤0.01% | 2379 |
|
|
2024
Q4 | $2.27M | Buy |
852,755
+21,211
| +3% | +$56.4K | ﹤0.01% | 2045 |
|
|
2024
Q3 | $1.9M | Buy |
831,544
+103,816
| +14% | +$238K | ﹤0.01% | 2072 |
|
|
2024
Q2 | $2.12M | Buy |
727,728
+22,323
| +3% | +$65.2K | ﹤0.01% | 1721 |
|
|
2024
Q1 | $2.57M | Sell |
705,405
-350,654
| -33% | -$1.28M | ﹤0.01% | 1663 |
|
|
2023
Q4 | $1.59M | Buy |
1,056,059
+1,054,766
| +81,575% | +$1.59M | ﹤0.01% | 1813 |
|
|
2023
Q3 | $1.73K | Sell |
1,293
-69,107
| -98% | -$92.6K | ﹤0.01% | 4243 |
|
|
2023
Q2 | $127K | Buy |
70,400
+32,926
| +88% | +$59.3K | ﹤0.01% | 3457 |
|
|
2023
Q1 | $62.2K | Buy |
37,474
+20,720
| +124% | +$34.4K | ﹤0.01% | 3570 |
|
|
2022
Q4 | $32.2K | Sell |
16,754
-6,493
| -28% | -$12.5K | ﹤0.01% | 3727 |
|
|
2022
Q3 | $52K | Sell |
23,247
-6,049
| -21% | -$13.5K | ﹤0.01% | 3655 |
|
|
2022
Q2 | $95K | Sell |
29,296
-8,740
| -23% | -$28.3K | ﹤0.01% | 3575 |
|
|
2022
Q1 | $200K | Sell |
38,036
-5,866
| -13% | -$30.8K | ﹤0.01% | 3401 |
|
|
2021
Q4 | $373K | Buy |
43,902
+14,380
| +49% | +$122K | ﹤0.01% | 3239 |
|
|
2021
Q3 | $293K | Buy |
29,522
+15,072
| +104% | +$150K | ﹤0.01% | 3196 |
|
|
2021
Q2 | $135K | Buy |
+14,450
| New | +$135K | ﹤0.01% | 3745 |
|